✓
Open
17 May 2023
✓
Close
19 May 2023
3
Allotment
—
✓
Listing
Mon, May 29, 2023
Price Band
₹1150 to ₹1229
Issue Size
3,88,000 shares (agg. up to ₹48 Cr)
Lot Size
100 Shares
Listing Date
Mon, May 29, 2023
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 42.54x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 33.53 | 15.91 | 11.05 | 5.30 |
| Total Income | 33.61 | 25.44 | 19.22 | 12.77 |
| Profit After Tax | 6.44 | 3.39 | 1.03 | 0.81 |
| NET Worth | 17.12 | 6.43 | 3.05 | 2.02 |
| Reserves and Surplus | 16.04 | 5.43 | 3.04 | 2.01 |
| Total Borrowing | 9.47 | 0.19 | 0.28 | 0.36 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹283.00 |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹90.05 |
| Trident Lifeline Ltd. | SME | ₹35.34 Cr | ₹101 | 51.53 | ₹108.15 | +7.08% | ₹294.00 |
| Dipna Pharmachem Ltd. | SME | ₹15.21 Cr | ₹38 | 39 | ₹33.40 | -12.11% | ₹4.89 |
| JFL Life Sciences Ltd. | SME | ₹18.17 Cr | ₹61 | 26.52 | ₹66.50 | +9.02% | ₹10.15 |
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,265.00 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirements | 30.30 |
| 2 | Funding investments for acquisitions and general corporate purposes | 16.38 |
| 3 | Public Issue Expenses | 1.00 |
About Remus Pharmaceuticals IPO
Updated on Aug 5, 2026
Contact Details
Remus Pharmaceuticals Ltd. Address1101 to 1103, South Tower, One 42B/H Ashok Vatika, Nr.Jayantilal Park BRTSAmbli bopal RoadAhmedabad, Gujarat, 380054+079- 2999 9857cs@remuspharma.comVisit Website